ABCG2 and breast cancer: When they examined the effect of another NO donor, DETNO, in BCRP-overexpressing MCF-7/MX human breast cancer cells, they found that NO from the NO donor directly inhibited the ATPase activity of BCRP, inducing significant intracellular drug accumulation.